This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
in this edition: Atacicept in IgAN; Albuminuria as a surrogate outcome, Renal Remission and additional CONFIDENCE analysis
It's a 15 oz (450 mL) mug because, let's face it, everyone knows that you have a coffee problem. No sense hiding it with a dainty cup. Go big. Zazzle swings NephJC a couple of bucks for every mug so we can start to pay off the hosting fees.